Federal solicitation · SPE2DP25R00070007 · back to recent
MIDAZOLAM INJECTION
- Agency
- DEPT OF DEFENSE
- Status
- Open
- Response deadline
- Not posted
- Posted
- September 22, 2026
- Set-aside
- Not listed
- NAICS
- 325411
- Estimated value
- $257.8M (as posted)
- Source
- View on SAM.gov
- Last checked
- 2026-09-23
Similar opportunities
Other open SAM.gov opportunities under the same NAICS, prioritizing the same buying agency.
| Title | Agency | Est. value | Basis |
|---|---|---|---|
| Pharm Manuf/Distr Div - FSA | DEPT OF DEFENSE | $133.2M | same agency naics |
| Pharm Manuf/Distr Div - FSA | DEPT OF DEFENSE | $18.5M | same agency naics |
| Pharm Manuf/Distr Div - FSA | DEPT OF DEFENSE | $2.4M | same agency naics |
| BATTERY,RECHARGEABLE,P | DEPT OF DEFENSE | - | same agency naics |
| NALOXONE HYDROCHLORIDE | DEPT OF DEFENSE | - | same agency naics |
| NIRMATRELVIR AND RI | DEPT OF DEFENSE | - | same agency naics |
| NALOXONE HYDROCHLOR | DEPT OF DEFENSE | - | same agency naics |
| NIRMATRELVIR AND RI | DEPT OF DEFENSE | - | same agency naics |
Data this profile does not cover
- No likely incumbent surfaced; the solicitation number did not match any award record in the trailing window.
- No award records for NAICS 325411 in the trailing 12 months, so the vendor field is unavailable.